|
?:authorAffiliation
|
-
[\'National Heart and Lung Institute, Imperial College London, London, UK; Chelsea and Westminster Hospital, London, UK; Royal Brompton and Harefield Hospitals, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK; Asthma UK Centre for Allergic Mechanisms of Asthma, London, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK.\', \'Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK; Margaret Turner-Warwick Centre for Fibrosing Lung Diseases, London, UK.\', \'Chelsea and Westminster Hospital, London, UK; Royal Brompton and Harefield Hospitals, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK; Asthma UK Centre for Allergic Mechanisms of Asthma, London, London, UK. Electronic address: j.harker@imperial.ac.uk.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}